In This Issue
- Apply for a Learning Health Systems Research K12 Award
- Covid-19 Specimen Biobank for Research
- Clinical Trials Help Through Nationwide Research Network
- New Research Platform for Health Data
- Research Community News and Updates
|
|
Apply for a Career Development Award in Learning Health Systems Research |
|
Faculty clinicians can now apply in the second round of awards from Einstein-Montefiore's EXPLORE program, one of only 11 programs nationwide awarded an Institutional Mentored Career Development Program (K12) from AHRQ and the Patient-Centered Outcomes Research Institute (PCORI). EXPLORE supports the training of clinicians and research scientists to conduct patient-centered outcomes research within learning health systems (LHS).
The program helps to develop LHS researchers who have the skill sets to conduct, apply, and implement patient-centered outcomes research to improve quality of care and patient outcomes in a learning health system. EXPLORE is seeking highly motivated, qualified candidates for this 2-to-3 year faculty development program, which comprises active engagement in mentored LHS research and performance improvement projects complemented by an individualized educational program. Candidates from underrepresented groups and those with disabilities are encouraged to apply.
Detailed information on the program and the application process can be found here.
|
|
Covid-19 Specimen Biobank Reminder |
|
The Biorepository established a specimen bank of samples from Covid-19 patients. The Covid-19 Biobank (>2,500 patients) is now become available to Einstein-Montefiore investigators. While the samples include serum, plasma, urine, and whole blood, you will need specific IRB approval for the research being considered. For example, several investigators have already been approved to receive deidentified samples for studying biomarkers related to infection or inflammation. On the other hand, studies that propose to examine patient DNA require additional review by the IRB because of the potential for genetic re-identification of the patient. We recommend that you discuss your needs in advance with the Biorepository Director (Daniel.stein@einsteinmed.org).
For more info, please contact us at ictr@einsteinmed.org. To be eligible for specimen distribution, you are required to submit the attached form by email, as indicated. A Covid-19 Biobank faculty review committee will evaluate and prioritize requests.
|
|
Clinical Trials Help Through Trial Innovation Network |
|
As a member of the NIH Trials Innovation Network, the Einstein-Montefiore community is able to tap into a nationwide network of specialists dedicated to improving participation in trials, as well as the overall quality and efficiency of research studies. Whether you are planning a study, in start-up, or implementing your trial, there are tools and resources you may be able to leverage to promote success. Learn more about the diverse services offered here or contact Zoe Tsagaris, Clinical Trials Network Manager, at zoe.tsagaris@einsteinmed.org for further information.
|
|
Institutional Data for Research Available |
|
In July, the Center for Health Data Innovations (CHDI) launched ATLAS, a self-service comprehensive clinical data research platform for health and administrative data from Montefiore Medical Center and all NYC medical centers (including more than 32,000 Covid-19 patient encounters). ATLAS is the internet browser-based tool that allows users to create and analyze patient cohorts from the newly implemented research database. Atlas users can define patient cohorts, compare baseline characteristics and differences between cohorts and/or subgroups within cohorts, measure incidence rates, and more to generate data for clinical research.
To learn more about the platform's capabilities and how to access, click here.
|
|
Research Community News and Updates |
|
AAHRPP Accreditation Update |
|
The Office of Human Research Affairs (OHRA) will be submitting the Association for Accreditation of Human Research Protection Program (AAHRPP) application this month. The application consists of a written description of the Einstein-Montefiore Human Subjects Protections Program policies and procedures. After the application review and revision process, a site visit will be scheduled to ensure that the policies and procedures included in the application have been implemented effectively. The site visit will likely occur sometime in 2021. Anyone who has a role in human research may be selected for an interview, including a number of researchers and research staff.
As a reminder, Einstein’s current policies and procedures can be found on OHRA’s website’s Policies and Procedures page. OHRA staff will be conducting outreach and educational sessions in the months leading up to the site visit.
|
|
Office of Human Research Affairs Feedback Survey |
|
In the spirit of continuous quality improvement, the Office of Human Research Affairs seeks ongoing feedback from the community it serves. To facilitate such feedback, OHRA created an online survey to gauge overall satisfaction with the OHRA in general, including the IRB review process, iRIS, and training opportunities. To access the survey, please click here. The link to the feedback survey may also be found on the main page of OHRA’s website.
|
|
Call-out for Submitting Proposals for Pfizer's CITI Program |
|
Pfizer’s Center for Therapeutic Innovation (CTI) is a unique joint drug discovery model focused on collaborating with leading academic medical centers to translate and transform concepts into breakthroughs that change patients’ lives.The deadline for submission is September 14, 2020. Please visit the Office of Biotechnology and Business Development website for more information and to download the pre-proposal submission form. The program is currently accepting proposals for Large Molecules only!
|
|
Einstein-Montefiore investigators continue to succeed in obtaining funding. Some of these investigators with new grant awards are (from left to right):
Harris Goldstein MD, Professor, Departments of Pediatrics (Pediatric Allergy & Immunology) and Microbiology & Immunology, Kartik Chandran PhD, Professor, Department of Microbiology & Immunology, Elyse Sussman PhD, Professor, Departments of Neuroscience and Otorhinolaryngology, and Mark Wagshul PhD, Associate Professor, Departments of Radiology and Physiology & Biophysics.
|
|
Research in the Headlines |
|
Harold and Muriel Block Institute for Clinical and Translational Research
|
|
|
|
|
|
|
